Viewing Study NCT06989359


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2026-02-02 @ 9:50 AM
Study NCT ID: NCT06989359
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-05-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Sponsor: ADARx Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None IgAN View
None C3G View
None Complement-mediated Kidney Disease View
Keywords: